GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conmed Corp (FRA:EC8) » Definitions » Cyclically Adjusted PB Ratio

Conmed (FRA:EC8) Cyclically Adjusted PB Ratio : 2.59 (As of Jun. 17, 2024)


View and export this data going back to . Start your Free Trial

What is Conmed Cyclically Adjusted PB Ratio?

As of today (2024-06-17), Conmed's current share price is €67.00. Conmed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €25.85. Conmed's Cyclically Adjusted PB Ratio for today is 2.59.

The historical rank and industry rank for Conmed's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:EC8' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.52   Med: 2.94   Max: 6.25
Current: 2.54

During the past years, Conmed's highest Cyclically Adjusted PB Ratio was 6.25. The lowest was 1.52. And the median was 2.94.

FRA:EC8's Cyclically Adjusted PB Ratio is ranked worse than
59.75% of 477 companies
in the Medical Devices & Instruments industry
Industry Median: 2.02 vs FRA:EC8: 2.54

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Conmed's adjusted book value per share data for the three months ended in Mar. 2024 was €25.536. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €25.85 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Conmed Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Conmed's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Conmed Cyclically Adjusted PB Ratio Chart

Conmed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.76 4.71 5.56 3.30 3.98

Conmed Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.82 4.95 3.65 3.98 2.86

Competitive Comparison of Conmed's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Conmed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conmed's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conmed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Conmed's Cyclically Adjusted PB Ratio falls into.



Conmed Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Conmed's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=67.00/25.85
=2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Conmed's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=25.536/131.7762*131.7762
=25.536

Current CPI (Mar. 2024) = 131.7762.

Conmed Quarterly Data

Book Value per Share CPI Adj_Book
201406 16.210 100.560 21.242
201409 16.714 100.428 21.931
201412 17.109 99.070 22.757
201503 19.233 99.621 25.441
201506 18.597 100.684 24.340
201509 18.573 100.392 24.379
201512 19.384 99.792 25.597
201603 18.848 100.470 24.721
201606 18.551 101.688 24.040
201609 18.711 101.861 24.206
201612 19.778 101.863 25.586
201703 19.312 102.862 24.740
201706 18.564 103.349 23.670
201709 17.715 104.136 22.417
201712 19.082 104.011 24.176
201803 18.592 105.290 23.269
201806 19.741 106.317 24.468
201809 19.888 106.507 24.607
201812 20.693 105.998 25.725
201903 21.734 107.251 26.704
201906 21.805 108.070 26.588
201909 22.433 108.329 27.288
201912 22.497 108.420 27.343
202003 22.266 108.902 26.943
202006 20.981 108.767 25.419
202009 20.282 109.815 24.338
202012 20.175 109.897 24.192
202103 20.961 111.754 24.716
202106 21.192 114.631 24.362
202109 21.971 115.734 25.016
202112 23.665 117.630 26.511
202203 24.288 121.301 26.385
202206 20.899 125.017 22.029
202209 23.739 125.227 24.981
202212 23.085 125.222 24.293
202303 22.997 127.348 23.797
202306 23.431 128.729 23.986
202309 24.264 129.860 24.622
202312 24.865 129.419 25.318
202403 25.536 131.776 25.536

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Conmed  (FRA:EC8) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Conmed Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Conmed's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Conmed (FRA:EC8) Business Description

Traded in Other Exchanges
Address
11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Conmed (FRA:EC8) Headlines

No Headlines